STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
Call AI in biotech hype at your peril.
There are real reasons that pharmaceutical companies are embracing this technology right now.
Call AI in biotech hype at your peril.
There are real reasons that pharmaceutical companies are embracing this technology right now.